The current status of adjuvant treatment for high-risk renal cell carcinoma. [electronic resource]
Producer: 20180814Description: 2017-2020 p. digitalISSN:- 1744-8301
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Chemotherapy, Adjuvant
- Clinical Trials, Phase III as Topic
- Combined Modality Therapy
- Humans
- Kidney Neoplasms -- drug therapy
- Neoplasm Grading
- Neoplasm Staging
- Protein Kinase Inhibitors -- therapeutic use
- Randomized Controlled Trials as Topic
- Treatment Outcome
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.